187 related articles for article (PubMed ID: 36639817)
21. Tet2 loss leads to hypermutagenicity in haematopoietic stem/progenitor cells.
Pan F; Wingo TS; Zhao Z; Gao R; Makishima H; Qu G; Lin L; Yu M; Ortega JR; Wang J; Nazha A; Chen L; Yao B; Liu C; Chen S; Weeks O; Ni H; Phillips BL; Huang S; Wang J; He C; Li GM; Radivoyevitch T; Aifantis I; Maciejewski JP; Yang FC; Jin P; Xu M
Nat Commun; 2017 Apr; 8():15102. PubMed ID: 28440315
[TBL] [Abstract][Full Text] [Related]
22. TET2 as a tumor suppressor and therapeutic target in T-cell acute lymphoblastic leukemia.
Bensberg M; Rundquist O; Selimović A; Lagerwall C; Benson M; Gustafsson M; Vogt H; Lentini A; Nestor CE
Proc Natl Acad Sci U S A; 2021 Aug; 118(34):. PubMed ID: 34413196
[TBL] [Abstract][Full Text] [Related]
23. TET enzymes control antibody production and shape the mutational landscape in germinal centre B cells.
Schoeler K; Aufschnaiter A; Messner S; Derudder E; Herzog S; Villunger A; Rajewsky K; Labi V
FEBS J; 2019 Sep; 286(18):3566-3581. PubMed ID: 31120187
[TBL] [Abstract][Full Text] [Related]
24. Demethylation of the RB1 promoter concomitant with reactivation of TET2 and TET3 impairs gastric carcinogenesis in K19-Wnt1/C2mE transgenic mice.
Cao D; Jia Z; Wu Y; Su T; Zhao D; Wu M; Tsukamoto T; Oshima M; Jiang J; Cao X
Life Sci; 2020 Dec; 263():118580. PubMed ID: 33058920
[TBL] [Abstract][Full Text] [Related]
25. TETology: Epigenetic Mastermind in Action.
Seethy A; Pethusamy K; Chattopadhyay I; Sah R; Chopra A; Dhar R; Karmakar S
Appl Biochem Biotechnol; 2021 Jun; 193(6):1701-1726. PubMed ID: 33694104
[TBL] [Abstract][Full Text] [Related]
26. Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells.
Blaschke K; Ebata KT; Karimi MM; Zepeda-Martínez JA; Goyal P; Mahapatra S; Tam A; Laird DJ; Hirst M; Rao A; Lorincz MC; Ramalho-Santos M
Nature; 2013 Aug; 500(7461):222-6. PubMed ID: 23812591
[TBL] [Abstract][Full Text] [Related]
27. Vitamin C down-regulate apo(a) expression via Tet2-dependent DNA demethylation in HepG2 cells.
Qu K; Ma XF; Li GH; Zhang H; Liu YM; Zhang K; Zeng JF; Lei JJ; Wei DH; Wang Z
Int J Biol Macromol; 2017 May; 98():637-645. PubMed ID: 28192139
[TBL] [Abstract][Full Text] [Related]
28. Comparative analysis of Tet2 catalytic-deficient and knockout bone marrow over time.
Flores JC; Ito K; Huang CY; Tang Q; Yanase C; Ito K; Dawlaty MM
Exp Hematol; 2023 Aug; 124():45-55.e2. PubMed ID: 37225048
[TBL] [Abstract][Full Text] [Related]
29. TET2 in Normal and Malignant Hematopoiesis.
Bowman RL; Levine RL
Cold Spring Harb Perspect Med; 2017 Aug; 7(8):. PubMed ID: 28242787
[TBL] [Abstract][Full Text] [Related]
30. Stage-specific roles for tet1 and tet2 in DNA demethylation in primordial germ cells.
Vincent JJ; Huang Y; Chen PY; Feng S; Calvopiña JH; Nee K; Lee SA; Le T; Yoon AJ; Faull K; Fan G; Rao A; Jacobsen SE; Pellegrini M; Clark AT
Cell Stem Cell; 2013 Apr; 12(4):470-8. PubMed ID: 23415914
[TBL] [Abstract][Full Text] [Related]
31. TET2 promoter methylation in low-grade diffuse gliomas lacking IDH1/2 mutations.
Kim YH; Pierscianek D; Mittelbronn M; Vital A; Mariani L; Hasselblatt M; Ohgaki H
J Clin Pathol; 2011 Oct; 64(10):850-2. PubMed ID: 21690245
[TBL] [Abstract][Full Text] [Related]
32. DNMT3A(R882H) mutant and Tet2 inactivation cooperate in the deregulation of DNA methylation control to induce lymphoid malignancies in mice.
Scourzic L; Couronné L; Pedersen MT; Della Valle V; Diop M; Mylonas E; Calvo J; Mouly E; Lopez CK; Martin N; Fontenay M; Bender A; Guibert S; Dubreuil P; Dessen P; Droin N; Pflumio F; Weber M; Gaulard P; Helin K; Mercher T; Bernard OA
Leukemia; 2016 Jun; 30(6):1388-98. PubMed ID: 26876596
[TBL] [Abstract][Full Text] [Related]
33. Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression.
Kamdar S; Isserlin R; Van der Kwast T; Zlotta AR; Bader GD; Fleshner NE; Bapat B
Clin Epigenetics; 2019 Mar; 11(1):54. PubMed ID: 30917865
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic Function of TET Family, 5-Methylcytosine, and 5-Hydroxymethylcytosine in Hematologic Malignancies.
Li W; Xu L
Oncol Res Treat; 2019; 42(6):309-318. PubMed ID: 31055566
[TBL] [Abstract][Full Text] [Related]
35. Research Advances in the Mutation of TET2 Gene in Myeloid Maligancies.
Li R; Xu MJ; Yang FC; Zhou Y
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Oct; 38(5):583-588. PubMed ID: 27825418
[TBL] [Abstract][Full Text] [Related]
36. Novel Mutations and Decreased Expression of the Epigenetic Regulator
Potus F; Pauciulo MW; Cook EK; Zhu N; Hsieh A; Welch CL; Shen Y; Tian L; Lima P; Mewburn J; D'Arsigny CL; Lutz KA; Coleman AW; Damico R; Snetsinger B; Martin AY; Hassoun PM; Nichols WC; Chung WK; Rauh MJ; Archer SL
Circulation; 2020 Jun; 141(24):1986-2000. PubMed ID: 32192357
[TBL] [Abstract][Full Text] [Related]
37. [TET2 gene in hematological diseases].
Li S; Wang XQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):836-41. PubMed ID: 24989305
[TBL] [Abstract][Full Text] [Related]
38. TET2 Promoter DNA Methylation and Expression in Childhood Acute Lymphoblastic Leukemia.
Bahari G; Hashemi M; Naderi M; Taheri M
Asian Pac J Cancer Prev; 2016; 17(8):3959-62. PubMed ID: 27644645
[TBL] [Abstract][Full Text] [Related]
39. Maternal vitamin C regulates reprogramming of DNA methylation and germline development.
DiTroia SP; Percharde M; Guerquin MJ; Wall E; Collignon E; Ebata KT; Mesh K; Mahesula S; Agathocleous M; Laird DJ; Livera G; Ramalho-Santos M
Nature; 2019 Sep; 573(7773):271-275. PubMed ID: 31485074
[TBL] [Abstract][Full Text] [Related]
40. MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy)methylation and gene expression to maintain a neoplastic phenotype in T-ALL.
Poole CJ; Lodh A; Choi JH; van Riggelen J
Epigenetics Chromatin; 2019 Jul; 12(1):41. PubMed ID: 31266538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
